ProShares Ultra NASDAQ Biotechnology
BIB
BIB
35 hedge funds and large institutions have $28.7M invested in ProShares Ultra NASDAQ Biotechnology in 2016 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 10 increasing their positions, 8 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
1% more call options, than puts
Call options by funds: $17.4M | Put options by funds: $17.3M
Holders
35
Holding in Top 10
1
Calls
$17.4M
Puts
$17.3M
Top Buyers
| 1 | +$4.12M | |
| 2 | +$2.25M | |
| 3 | +$1.81M | |
| 4 |
BA
BKS Advisors
Southfield,
Michigan
|
+$1.79M |
| 5 |
BG
Bellevue Group
Kuesnacht,
Switzerland
|
+$1.21M |
Top Sellers
| 1 | -$2.84M | |
| 2 | -$2.24M | |
| 3 | -$1.32M | |
| 4 |
RIA
RPG Investment Advisory
Pleasanton,
California
|
-$867K |
| 5 |
Jane Street
New York
|
-$676K |